Becker's Hospital Review

New data shows use of T2 Biosystem’s diagnostic panel for rapid detection of sepsis, caused by Candida, could save hospitals millions of dollars annually

New data shows use of T2 Biosystem’s diagnostic panel for rapid detection of sepsis, caused by Candida, could save hospitals millions of dollars annually With sepsis claiming 500,000 lives1 in the U.S ...
Seeking Alpha

T2 Biosystems Achieves Successful Defense of Patent for Direct-From-Whole Blood Pathogen Detection Method in the European Union

LEXINGTON, Mass., Sept. 20, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today ...
Nasdaq

T2 Biosystems Extends Supplier Agreement with Vizient Through March 2026 for Rapid Sepsis Detection Products

The press release heavily relies on forward-looking statements, indicating a potential lack of concrete results and leaving room for uncertainty about the company's future performance. There is an ...
Seeking Alpha

T2 Biosystems Announces Exclusive U.S. Agreement with Cardinal Health to Sell its FDA-Cleared Direct-From-Blood Diagnostics for Rapid Detection of Sepsis-Causing Pathogens

LEXINGTON, Mass., Oct. 07, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today ...